Related Experiment Videos
Immune-mediated rippling muscle disease
W J Schulte-Mattler1, R A Kley, E Rothenfusser-Korber
1Department of Neurology, University of Regensburg, Germany.
Neurology
|January 26, 2005
Summary
Rippling muscle disease (RMD) can occur without caveolin-3 gene mutations. This case study reveals reduced caveolin-3, altered dysferlin, and autoantibodies in RMD, suggesting broader autoimmune involvement in muscle disorders.
Area of Science:
- Neurology
- Muscle Biology
- Immunology
Background:
- Rippling muscle disease (RMD) is a rare neuromuscular disorder.
- Mutations in the caveolin-3 gene are the most common cause of RMD.
- The underlying pathophysiology of RMD in non-caveolin-3 mutation cases is not fully understood.
Observation:
- A 44-year-old male patient presented with RMD.
- The patient lacked mutations in the caveolin-3 gene.
- Muscle biopsy revealed reduced caveolin-3 expression and a mosaic pattern of dysferlin.
- Ultrastructural analysis showed loss of caveolae and triad alterations.
Findings:
- The muscle biopsy demonstrated a marked reduction of caveolin-3.
- Dysferlin immunostaining showed a mosaic pattern, indicating potential sarcolemmal defects.
- Ultrastructural findings suggest disruption of sarcolemmal organization and T-tubule system.
- Autoantibodies against the sarcolemma, triad, and unknown muscle proteins were detected.
Implications:
- This case expands the known genetic and molecular basis of Rippling Muscle Disease.
- The presence of autoantibodies suggests an autoimmune component in some RMD cases.
- Understanding these alternative pathways is crucial for diagnosing and potentially treating RMD.
- Further research into the identified autoantigens may reveal novel therapeutic targets for muscle disorders.